Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy

被引:0
作者
Naoko Iwamoto
Tomoyuki Aruga
Shinichiro Horiguchi
Chiaki Saita
Mai Onishi
Risa Goto
Toshiyuki Ishiba
Yayoi Honda
Hiromi Miyamoto
Katsumasa Kuroi
机构
[1] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Breast Surgery
[2] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Pathology
[3] Tokyo Metropolitan Health and Hospitals Corporation Ebara Hospital,Department of Breast Surgery
来源
Surgery Today | 2020年 / 50卷
关键词
Node-positive; Breast cancer; Neoadjuvant; Axillary lymph node dissection;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:178 / 184
页数:6
相关论文
共 111 条
[1]  
Boughey JC(2013)Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the American college of surgeons oncology group (ACOSOG) Z1071 clinical Trial JAMA 310 1455-1461
[2]  
Suman VJ(2013)Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study Lancet Oncol. 14 609-618
[3]  
Mittendorf EA(2015)Feasibility trial for selective surgical localization of axillary lymph nodes containing metastases in breast cancer patients JAMA Surg. 150 137-143
[4]  
Ahrendt GM(2016)Radiologic mapping for targeted axillary dissection: needle biopsy to excision AJR. 207 372-379
[5]  
Wilke LG(2018)Intraoperative ultrasound-guided excision of axillary clip in patients with no de-positive breast cancer treated with neoadjuvant therapy (ILINA trial): a new tool to guide the excision of the clipped node after neoadjuvant treatment Ann Surg Oncol. 25 784-791
[6]  
Taback B(2018)Feasibility of preoperative axillary lymph node marking with a clip in breast cancer patients before neoadjuvant chemotherapy: a preliminary study World J Surg. 42 582-589
[7]  
Kuehn T(2018)Intraoperative touch imprint cytology in targeted axillary dissection after neoadjuvant chemotherapy for breast cancer patients with initial axillary metastasis Ann Surg Oncol. 25 3150-3157
[8]  
Bauerfeind I(2013)Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial Lancet Oncol. 14 297-305
[9]  
Fehm T(2018)A predictive model for axillary node pathologic complete response after neoadjuvant chemotherapy for breast cancer Ann Surg Oncol 23 3501-3509
[10]  
Fleige B(2016)Nomograms for predicting axillary response to neoadjuvant chemotherapy in clinically node-positive patients with breast cancer Ann Surg Oncol. 24 2518-2525